Form 4: Avanos Medical SVP Michael Greiner Reports Changes in Beneficial Ownership

Michael Greiner, SVP and CFO of Avanos Medical, reports acquisition and disposal of common stock and vesting of restricted share units.

Summary

• On March 6, 2024, Michael Greiner, SVP and CFO of Avanos Medical, reported changes in beneficial ownership of the company's stock.
• Greiner acquired 57,471 shares of common stock at a price of $19.14.
• These shares were time-based restricted share units (TRSUs) awarded under the company's 2021 Long Term Incentive Plan, as amended, vesting in three equal installments on March 6, 2025, 2026, and 2027.
• Greiner also disposed of 5,118 shares at $19 to cover tax withholding obligations related to the vesting of TRSUs awarded on March 6, 2023.
• Following these transactions, Greiner beneficially owns 159,495 shares of Avanos Medical common stock.
• This total includes 448 shares acquired on December 31, 2023, and 382 shares acquired on June 30, 2023, under the company's Employee Stock Purchase Plan.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to stock transactions by an executive. It doesn't inherently convey positive or negative sentiment about the company's performance.

Positives

• The acquisition of a significant number of shares by a high-ranking executive could be interpreted as a positive signal about the company's future prospects.

Negatives

• The disposal of shares to cover tax obligations is a routine transaction and doesn't necessarily indicate a negative outlook, but it does reduce the executive's holdings.

Risks

• The vesting of restricted stock units is tied to continued employment, so there is a risk that the executive may leave the company before all units vest.

Future Outlook

The document does not contain any specific forward-looking statements regarding the company's financial performance or future prospects.

Industry Context

This filing is a routine disclosure related to insider trading and is a normal part of corporate governance. It doesn't provide specific insights into Avanos Medical's competitive position or industry trends.

Stakeholder Impact

• The transactions may have a minor impact on shareholders' perception of the company, depending on how they interpret the executive's stock activity.
• Employees participating in the Employee Stock Purchase Plan are also stakeholders affected by stock transactions.

Key Dates